Involvement of ERK1/2 pathway in BPC-157-induced cell proliferation, migration, and tube formation To explore whether the ERK1/2, JNK, or p38 pathway was involved in BPC-157-induced cell proliferation, migration, and tube formation, PD98059 (ERK1/2 inhibitor), SP600125 (JNK inhibitor), and SB203580 (p38 inhibitor) were used
Band intensities were quantitated by densitometry
Pregnancy and breastfeeding require individualized risk-benefit assessment
Table 11 The effect of different tonicity agents on co-formulation physical stability Results are the mean of 2 replicates and has been rounded to nearest integer value (-) Sampling not performed 1 For co-formulation 12 with NaCI, sampling was discontinued earlier than for the other formulations because of the rapid increase in sub-visible particle counts
According to the National Institutes of Health, the FDA has not approved BPC-157 because of concerns about its safety in humans
Is InfiniWell BPC RAPID a Scam